Laws on disclosure of trial data by drug companies are to be toughened up, the BBC helpfully tells us, after GlaxoSmithKline (GSK) were accused of being too slow to raise the alarm over Seroxat and the risk of suicidal behaviour. This stems from May 2003 when the Medicines and Healthcare Products Regulatory Agency (MHRA) received data from GSK confirming ...
Posted on EU Referendum.
Thursday, 6 March 2008
Another EU failure
